Cancer discovery
The most recent articles from:
Cancer Discov
-
As significant increases in the costs of cancer drugs cause financial difficulties for many U. S. patients, some oncologists suggest that changes in pricing policies at the federal and state levels are inevitable.
-
Targeting the KRAS-PDEδ interaction inhibits KRAS-dependent signaling and tumor growth.
-
The U. S. Food and Drug Administration approved radium-223 dichloride for treatment of men with metastatic castration-resistant prostate cancer that has spread to the bone.
-
Colony-stimulating factor 3 receptor (CSF3R) is mutated in 59% of CNL or atypical CML cases.